Patents by Inventor Assaf Shechter

Assaf Shechter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Functional sex-reversal of decapod crustacean females
    Patent number: 11624052
    Abstract: The present invention provides a primary cell culture which combines a cell culture medium and cells derived from a hypertrophied androgenic gland (AG) of a decapod crustacean. The invention also provides methods for obtaining an all-female progeny by initially injecting/transplanting the primary cell culture to a genetic-female to obtain a male-Neo-male.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: April 11, 2023
    Assignee: ENZOOTIC HOLDINGS LTD.
    Inventors: Assaf Shechter, Ohad Rosen, Amir Sagi
  • WW homogametic male decapod crustacean and methods of using the same
    Patent number: 10791721
    Abstract: The present invention provides an all-female progeny of a decapod crustacean. The invention further provides the newly created: WW homogametic Neo-male decapod crustacean and WW homogametic female decapod crustacean. The crossing of WW homogametic Neo-male decapod crustacean and WW homogametic female decapod crustacean resulted in a 100% homogametic all-WW female progeny.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: October 6, 2020
    Assignee: ENZOOTIC HOLDINGS LTD.
    Inventors: Assaf Shechter, Ohad Rosen, Amir Sagi
  • Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders
    Patent number: 10688124
    Abstract: Provided are methods for treating calcium malabsorption and conditions associated with calcium malabsorption, employing the administration of a composition containing stable amorphous calcium carbonate. Further provided are methods for increasing bone mineral density in a bone metabolism associated disorders, diseases or conditions, employing the administration of said composition in combination with a bone resorption inhibitor.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: June 23, 2020
    Assignee: AMORPHICAL LTD
    Inventors: Amir Sagi, Assaf Shechter, Galit Shaltiel-Gold, Michal Daniely, Oren Meiron
  • FUNCTIONAL SEX-REVERSAL OF DECAPOD CRUSTACEAN FEMALES
    Publication number: 20200190467
    Abstract: The present invention provides a primary cell culture which combines a cell culture medium and cells derived from a hypertrophied androgenic gland (AG) of a decapod crustacean. The invention also provides methods for obtaining an all-female progeny by initially injecting/transplanting the primary cell culture to a genetic-female to obtain a male-Neo-male.
    Type: Application
    Filed: February 24, 2020
    Publication date: June 18, 2020
    Inventors: Assaf SHECHTER, Ohad ROSEN, Amir SAGI
  • Functional sex-reversal of decapod crustacean females
    Patent number: 10570368
    Abstract: The present invention provides a primary cell culture which combines a cell culture medium and cells derived from a hypertrophied androgenic gland (AG) of a decapod crustacean. The invention also provides methods for obtaining an all-female progeny by initially injecting/transplanting the primary cell culture to a genetic-female to obtain a male-Neo-male.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: February 25, 2020
    Assignee: ENZOOTIC HOLDINGS LTD.
    Inventors: Assaf Shechter, Ohad Rosen, Amir Sagi
  • Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides
    Patent number: 10328100
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: June 25, 2019
    Assignee: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • AMORPHOUS CALCIUM CARBONATE FOR THE TREATMENT OF CALCIUM MALABSORPTION AND METABOLIC BONE DISORDERS
    Publication number: 20190022133
    Abstract: Provided are methods for treating calcium malabsorption and conditions associated with calcium malabsorption, employing the administration of a composition containing stable amorphous calcium carbonate. Further provided are methods for increasing bone mineral density in a bone metabolism associated disorders, diseases or conditions, employing the administration of said composition in combination with a bone resorption inhibitor.
    Type: Application
    Filed: July 31, 2018
    Publication date: January 24, 2019
    Inventors: Amir SAGI, Assaf SHECHTER, Galit SHALTIEL-GOLD, Michal DANIELY, Oren MEIRON
  • A WW HOMOGAMETIC MALE DECAPOD CRUSTACEAN AND METHODS OF USING THE SAME
    Publication number: 20180317467
    Abstract: The present invention provides an all-female progeny of a decapod crustacean. The invention further provides the newly created: WW homogametic Neo-male decapod crustacean and WW homogametic female decapod crustacean. The crossing of WW homogametic Neo-male decapod crustacean and WW homogametic female decapod crustacean resulted in a 100% homogametic all-WW female progeny.
    Type: Application
    Filed: November 10, 2016
    Publication date: November 8, 2018
    Inventors: Assaf SHECHTER, Ohad ROSEN, Amir SAGI
  • Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders
    Patent number: 10064890
    Abstract: Provided are methods for treating calcium malabsorption and conditions associated with calcium malabsorption, employing the administration of a composition containing stable amorphous calcium carbonate. Further provided are methods for increasing bone mineral density in a bone metabolism associated disorders, diseases or conditions, employing the administration of said composition in combination with a bone resorption inhibitor.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: September 4, 2018
    Assignee: AMORPHICAL LTD.
    Inventors: Amir Sagi, Assaf Shechter, Galit Shaltiel-Gold, Michal Daniely, Oren Meiron
  • FUNCTIONAL SEX-REVERSAL OF DECAPOD CRUSTACEAN FEMALES
    Publication number: 20170313975
    Abstract: The present invention provides a primary cell culture which combines a cell culture medium and cells derived from a hypertrophied androgenic gland (AG) of a decapod crustacean. The invention also provides methods for obtaining an all-female progeny by initially injecting/transplanting the primary cell culture to a genetic-female to obtain a male-Neo-male.
    Type: Application
    Filed: November 13, 2015
    Publication date: November 2, 2017
    Inventors: Assaf SHECHTER, Ohad ROSEN, Amir SAGI
  • STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES
    Publication number: 20160045546
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: June 19, 2015
    Publication date: February 18, 2016
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel BENTOV, Amir SAGI, Amir BERMAN, Assaf SHECHTER
  • AMORPHOUS CALCIUM CARBONATE FOR THE TREATMENT OF CALCIUM MALABSORPTION AND METABOLIC BONE DISORDERS
    Publication number: 20150056306
    Abstract: Provided are methods for treating calcium malabsorption and conditions associated with calcium malabsorption, employing the administration of a composition containing stable amorphous calcium carbonate. Further provided are methods for increasing bone mineral density in a bone metabolism associated disorders, diseases or conditions, employing the administration of said composition in combination with a bone resorption inhibitor.
    Type: Application
    Filed: December 13, 2012
    Publication date: February 26, 2015
    Inventors: Amir Sagi, Assaf Shechter, Galit Shaltiel-Gold, Michal Daniely, Oren Meiron
  • Stable amorphous calcium carbonate comprising phosphorylated amino acids
    Patent number: 8802160
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid which stabilizes the amorphous form of said calcium carbonate. The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: August 12, 2014
    Assignee: Amorphical Ltd.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING PHOSPHORYLATED AMINO ACIDS
    Publication number: 20100310677
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid which stabilizes the amorphous form of said calcium carbonate. The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: October 22, 2008
    Publication date: December 9, 2010
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES
    Publication number: 20100221362
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: April 22, 2010
    Publication date: September 2, 2010
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter